GlassScriptPhysician profile
Guy M Shoaf
NPI 1548255409
$2,486.01
in general payments reported to CMS, 2019-2025
26 companies · $963 in 2025
The $963 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $38.31 · 2021: $257 · 2022: $60.21 · 2023: $296 · 2024: $253 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $682.54 | 2021-2025 | Barrigel, Urolift |
| Astellas Pharma US INC | $359.03 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $210.57 | 2019-2022 | |
| Medtronic, INC. | $177.86 | 2021-2025 | Interstim |
| Pfizer INC. | $169.99 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $167.16 | 2019-2020 | |
| Calyxo, INC. | $126.10 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $79.87 | 2023-2025 | Gemtesa |
| Endo USA, INC. | $67.93 | 2025 | Xiaflex, Aveed |
| Kowa Pharmaceuticals America, INC. | $55.50 | 2023 | Seglentis |
| Boston Scientific Corporation | $51.74 | 2023-2025 | Axonics, Rezum Generator |
| Cook Medical LLC | $50.46 | 2019 | |
| Urogen Pharma, INC. | $36.88 | 2025 | |
| Olympus America INC. | $33.08 | 2025 | Itind System |
| Axonics, INC. | $32.53 | 2021-2024 | Bulkamid, Axonics |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $27.89 | 2022-2025 | |
| Hollister Incorporated | $21.50 | 2023 | Infyna Chic |
| Bayer Healthcare Pharmaceuticals INC. | $19.42 | 2024 | |
| Urovant Sciences INC | $18.77 | 2022 | |
| Davol INC. | $17.18 | 2024 | Arista Ah Flexitip |
| Endo Pharmaceuticals INC. | $15.32 | 2021 | |
| Blue Earth Diagnostics | $14.98 | 2024 | |
| Medtronic USA, INC. | $14.25 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.50 | 2025 | |
| Procept Biorobotics Corporation | $13.42 | 2024 | Aquabeam System |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Shoaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.